Pancreatic Leaks and Fistulae: Pathophysiological Principles
Journal Title: Pancreas – Open Journal - Year 2018, Vol 2, Issue 1
Abstract
Pancreatic fistula is one of the common complications that may arises after upper gastrointestinal surgery, acute pancreatitis and, more rarely, abdominal traumas. The treatment is mainly based on conservative therapy. However, for persistent ones, endoscopical management is now-a-days considered as the surgical one. In this brief discussion, we want to focus the pathophysiological bases of endoscopic treatment for pancreatic leaks and fistulas.
Authors and Affiliations
Lorenzo Dioscoridi
Keywords
Related Articles
- EP ID EP556734
- DOI 10.17140/POJ-2-e006
- Views 164
- Downloads 0
Effects of Obesity and Diabetes on Beta-Cell Mass in Japanese
The prevalence of type 2 diabetes mellitus (T2DM) continues to increase all over the world. T2DM is characterized by insulin resistance and β-cell dysfunction. Recent studies have shown that β-cell dysfunction, but not i...
PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Programmed cell death protein 1 (PD-1), a member of the CD28 family, is an immune-checkpoint receptor expressed on a variety of immune cells, such as T-cells, monocytes, B-cells, dendritic cells, and tumor-infiltrating l...
β-cell Heterogeneity: The Key to β-cell Replacement Therapy
Cellular heterogeneity is crucial for organisms to adapt to their environmental changes. It provides the morphological, functional and molecular diversity that allows tissues and organs to respond to stressors and mainta...
The Enigma of Type 3c Diabetes in Chronic Pancreatitis
Pancreatogenic or Type 3c diabetes (T3cDM) is relatively a new entry in the complex world of diabetes study. While the general population and physicians are well aware of type 1 and type 2 diabetes mellitus, as evidenced...
ADAM10 Proteases and Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related deaths in the United States and is expected to rise to the second rank by 2020.1 The survival rate of PDAC is estimated at less than 5% a...